RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Jose L. Lopez-Ribot to Drug Discovery

Back to Details
This is a "connection" page, showing publications Jose L. Lopez-Ribot has written about Drug Discovery.
Jose L. Lopez-Ribot
Connection Strength
1.104
Drug Discovery
  1. Vila T, Romo JA, Pierce CG, McHardy SF, Saville SP, Lopez-Ribot JL. Targeting Candida albicans filamentation for antifungal drug development. Virulence. 2017 02 17; 8(2):150-158.
    View in: PubMed
    Score: 0.533
  2. Pierce CG, Lopez-Ribot JL. Candidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugs. Expert Opin Drug Discov. 2013 Sep; 8(9):1117-26.
    View in: PubMed
    Score: 0.433
  3. Srinivasan A, Leung KP, Lopez-Ribot JL, Ramasubramanian AK. High-throughput nano-biofilm microarray for antifungal drug discovery. mBio. 2013 Jun 25; 4(4).
    View in: PubMed
    Score: 0.109
  4. Srinivasan A, Lopez-Ribot JL, Ramasubramanian AK. Microscale microbial culture. Future Microbiol. 2015; 10(2):143-6.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support